Companies /Consumer Defensive
Clorox Company
NYSE: CLX Household & Personal Products
$109.46
▲ $1.26 (+1.16%) today
Markets closed · 8:35am ET

Clorox Company (CLX) Q1 2027 Earnings

Reported Nov 2, 2026, 4:10pm ET
$1.55
Beat +44.62%
EPS · est. $1.07 Adjusted

Adjusted EPS excludes $0.16 per share of GOJO acquisition and integration costs (approximately $26 million pre-tax, $20 million after tax). Year-ago comparison lapped ERP transition-related inventory drawdown worth about 90 cents of EPS.

$1.9B
Beat +1.54%
Revenue · est. $1.9B
3 quarters
Consecutive EPS beats

How Did CLX Stock React to Q1 2027 Earnings?

+4.34%
Day of report
+5.71%
Next session
+13.65%
One week

Did CLX Beat Earnings? Q1 2027 Results

Yes. Clorox Company reported Q1 2027 earnings of $1.55 a share on Nov 2, 2026, beating the $1.07 consensus estimate by 44.6%. Revenue was $1.9B against a $1.9B estimate.

The Clorox Company kicked off fiscal 2027 with a decisive earnings beat, posting adjusted EPS of $1.55 against a consensus of $1.07, a gap of 44.62%, while revenue of $1.91 billion edged past estimates by 1.54% and surged 33.3% year over year. Two forces did much of the heavy lifting: the April 2026 acquisition of GOJO, maker of Purell, contributed roughly 15 points of that revenue growth, while the year-ago quarter had been depressed by retailer inventory drawdowns tied to Clorox's U.S. ERP transition, a headwind management estimated cost about $0.90 of adjusted EPS at the time. Gross margin slipped 130 basis points to 40.4% as commodity, manufacturing and logistics costs rose, and interest expense more than doubled to $52 million following the debt-financed GOJO deal. <a href="https://247wallst.com/investing/2026/10/27/is-cloroxs-6-dividend-yield-safe-the-nov-2-earnings-report-could-decide/">Investors watching the dividend</a> will note that full-year adjusted EPS guidance of $5.70 to $6.00 was maintained, though management now expects results closer to the low end given a more challenging input-cost environment.

Key Takeaways
  • Net sales up 33%, driven by 31 points of higher volume and 2 points of favorable price mix
  • GOJO acquisition contributed about 15 points of net sales growth
  • About 18 points of benefit from lapping the ERP transition-related inventory drawdown in the year-ago quarter
  • One of the strongest quarters of cost savings on record
  • Lower tax rate supported adjusted EPS
  • Higher commodity, manufacturing and logistics costs pressured gross margin, which fell 130 basis points to 40.4%
  • GOJO inventory step-up reduced gross margin by about 50 basis points
  • International organic volume growth of 9%, led by Latin America

“We entered this fiscal year focused on steadily improving performance while navigating continued input cost pressures. We made good progress in the first quarter, delivering better-than-expected results through strong execution and timing benefits.”

Clorox Company CEO, on the earnings call

What Is Clorox Company's Outlook?

Clorox kept its fiscal 2027 sales and adjusted EPS ranges but expects adjusted EPS closer to the low end because of higher input costs. - **Net sales:** expected up 13% to 14%, including about 9.5 points from GOJO. - **Organic sales:** expected up 3.5% to 4.5%, including more than 3.5 points of benefit from lapping the ERP-related drawdown. - **Gross margin:** now about 41.5%, including about 20 basis points of negative impact mainly from the GOJO inventory step-up. - **Selling and administrative expenses:** now about 15.5% of net sales, including about 40 basis points from GOJO transaction costs. - **Advertising and sales promotion:** about 10% of net sales. - **Effective tax rate:** about 23%. - **Diluted EPS:** $5.41 to $5.71, up 12% to 19%, including about 29 cents of GOJO transaction-related costs. - **Adjusted EPS:** $5.70 to $6.00, up 3% to 8%.

CLX YoY Financials

Q1 2027 vs Q1 2026 · SEC filings Q1 2026 Q1 2027
$0$600.0M$1.2B$1.8B$1.4B$1.9BRevenue$594.0M$770.0MGross Profit$80.0M$170.0MNet Income
$0$600.0M$1.2B$1.8BRevenueGross ProfitNet Income
CLX income statement, Q1 2027 versus Q1 2026
Metric Q1 2027 Q1 2026 Year over year
Revenue $1.9B $1.4B +33.3%
Gross Profit $770.0M $594.0M +29.6%
Net Income $170.0M $80.0M +112.5%

CLX Revenue by Segment

Health and Wellness$918.0M+62.0%
Household$423.0M+17.0%
Lifestyle$283.0M+16.0%
International$281.0M+11.0%

When Does Clorox Company Report Next?

Expected report date

Figures from SEC filings and company reports. Not investment advice.